Selective targeting of FAK–Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells

This publication has 43 references indexed in Scilit:

• Compensatory Function of Pyk2 Protein in the Promotion of Focal Adhesion Kinase (FAK)-null Mammary Cancer Stem Cell Tumorigenicity and Metastatic Activity
  Journal of Biological Chemistry, 2011
• Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
  Journal of Cell Science, 2010
• Comparison of methods for evaluating drug-drug interaction
  Frontiers in Bioscience-Elite, 2010
• Targeting Pyk2 for therapeutic intervention
  Expert Opinion on Therapeutic Targets, 2009
• Vitamin C and -naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats
  Carcinogenesis, 2009
• Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK
  Journal of Cell Biology, 2008
• Targeting multidrug resistance in cancer
  Nature Reviews Drug Discovery, 2006
• Focal adhesion kinase: in command and control of cell motility
  Nature Reviews Molecular Cell Biology, 2005
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
  Pharmacological Reviews, 2004
• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
  Biochemical Pharmacology, 1999